Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist PegvisomantPeter Trainer, John A. Scarlett, A.J. van der Lely et al.|New England Journal of Medicine|2000Cited by 874
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonistAart Jan van der Lely, Michael O. Thorner, R. Kent Hutson et al.|The Lancet|2001Cited by 643
Long-Term Mortality after Transsphenoidal Surgery and Adjunctive Therapy for Acromegaly<sup>1</sup>Brooke Swearingen, Nicholas T. Zervas, Fred G. Barker et al.|The Journal of Clinical Endocrinology & Metabolism|1998Cited by 587
Decreased Bone Density in Hyperprolactinemic WomenAnne Klibanski, Janet W. McArthur, Robert M. Neer et al.|New England Journal of Medicine|1980Cited by 363
Growth Hormone (GH) Replacement Therapy in Adult-Onset GH Deficiency: Effects on Body Composition in Men and Women in a Double-Blind, Randomized, Placebo-Controlled TrialAndrew R. Hoffman, Mary Lee Vance, Joyce Kuntze et al.|The Journal of Clinical Endocrinology & Metabolism|2004Cited by 185